<?xml version="1.0" encoding="UTF-8"?>
<p>Fifteen people were seropositive for RVFV hence the seroprevalence in the community was 0.8% (95% CI 0.5–1.3%). The survey-adjusted seroprevalence was 0.5% (95% CI 0.2–0.8%). The true prevalence accounting for the sensitivity and specificity of the diagnostic test was 0.1% (95% CI 0.0–0.2%).</p>
